CONTRACTILITY IN EXPERIMENTAL VOLUME OVERLOAD
实验体积过载中的收缩性
基本信息
- 批准号:3354270
- 负责人:
- 金额:$ 11.96万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1988
- 资助国家:美国
- 起止时间:1988-03-01 至 1993-02-28
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Prolonged left ventricular volume overload in man results in
reduced contractile function and poor pump performance. The
mechanisms leading to contractile dysfunction are difficult to
study in man because of obvious ethical constraints and because
few patients are ever followed from the onset of their volume
overload through the period of compensated eccentric
hypertrophy to the point of ventricular dysfunction. Experimental
models of volume overload would be useful in studying the
mechanisms of ventricular dysfunction that occur but
unfortunately these models usually do not produce left ventricular
dysfunction. Thus, models of right ventricular volume overload
(which are probably not germane to left ventricular volume
overload) have not produced a contractile deficit . Left
ventricular models which have used complete heart block or
various AV fistulas have usually demonstrated normal contractiles
function although one such model did demonstrate a contractile
deficit.
In this proposal we will study contractile function in pure volume
overload as produced by a unique closed chest model of mitral
regurgitation. We will use the mean velocity of circumferential
fiber shortening-stress relationship, which is relatively load
independent, to assess contractile function longitudinally as
volume overload hypertrophy develops. Pilot data using this
model suggests that in fact a contractile deficit does occur. IF A
CONTRACTILE DEFICIT DOES OCCUR, WE WILL ATTEMPT TO
ASCERTAIN WHETHER THE DEFICIT IS A PROPERTY OF THE
ABNORMAL CHAMBER GEOMETRY PRODUCED BY VOLUME
OVERLOAD OR DUE TO INTRINSIC MYOCARDIAL CELLULAR
DYSFUNCTION. On a more clinical level it is obvious that mitral
valve replacement results in a fall in pump performance
postoperatively. This diminution in performance ranges from mild
to severe but almost always occurs and is usually irreversible.
While the traditional explanation for this fall in pump
performance is that it is due to increased afterload due to
removal of the low impedence pathway into the left atrium this
point is controversial. In this proposal we will perform mitral
valve replacement in chronic mitral regurgitation. We will then
examine in a systematic fashion 1) reduced contractile
performance, 2) increased afterload, 3) inability of additional
hypertrophy to offset the increased afterload, and 4) removal of
the papillary mitral complex as possible mechanisms for the
postoperative fall in performance seen following mitral value
replacement.
人体长期左心室容量超负荷导致
收缩功能降低和泵性能差。 的
导致收缩功能障碍的机制很难
因为明显的伦理约束,
很少有患者从其体积开始就被跟踪,
过补偿偏心周期过载
肥大到心室功能障碍的程度。 实验
容量超负荷模型将有助于研究
心室功能障碍的发生机制,但
不幸的是,这些模型通常不产生左心室
功能障碍 因此,右心室容量超负荷模型
(可能与左心室容积无关
(1)没有产生可收缩的赤字。 左
心室模型使用了完全性心脏传导阻滞或
各种动静脉瘘通常表现出正常的收缩
尽管一个这样的模型确实证明了收缩功能,
赤字
本文将研究纯体积中的收缩函数
由二尖瓣的独特闭合胸部模型产生的过载
返流程度 我们将使用圆周的平均速度
纤维短缩-应力关系,即相对载荷
独立,纵向评估收缩功能,
出现容量超负荷肥大。 试点数据使用此
模型表明,事实上,收缩赤字确实发生。 如果
如果出现机械故障,我们将尝试
确定缺陷是否是
体积产生的异常腔体几何形状
超负荷或由于固有心肌细胞
功能障碍。 在更临床的水平上,很明显二尖瓣
阀门更换导致泵性能下降
手术后。 这种性能下降的范围从轻微的
但几乎总是发生,通常是不可逆的。
虽然传统的解释,这种下降在泵
性能是,这是由于增加后负荷,由于
去除进入左心房的低阻抗通路,
这一点有争议。 在本提案中,我们将执行二尖瓣
慢性二尖瓣返流的瓣膜置换术 然后我们将
以系统的方式检查1)收缩减少
性能,2)增加后负荷,3)无法额外的
肥大,以抵消增加的后负荷,和4)去除
乳头状二尖瓣复合体可能是
二尖瓣关闭不全术后性能下降
更换.
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
BLASE A CARABELLO其他文献
BLASE A CARABELLO的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('BLASE A CARABELLO', 18)}}的其他基金
CORONARY BLOOD FLOW IN SUB CORONARY AORTIC STENOSIS
冠状动脉瓣下狭窄的冠状动脉血流
- 批准号:
3352302 - 财政年份:1985
- 资助金额:
$ 11.96万 - 项目类别:
相似海外基金
Wearable devices for reducing congestive heart failure hospitalizations
可减少充血性心力衰竭住院次数的可穿戴设备
- 批准号:
568003-2022 - 财政年份:2022
- 资助金额:
$ 11.96万 - 项目类别:
Postdoctoral Fellowships
Remote ischemic preconditioning for renal and cardiac protection in congestive heart failure (RICH) trial
充血性心力衰竭 (RICH) 试验中远程缺血预处理对肾脏和心脏的保护
- 批准号:
10426064 - 财政年份:2021
- 资助金额:
$ 11.96万 - 项目类别:
Novel target mechanism (renal nerves) for the beneficial actions of SGLT2 inhibition in congestive heart failure
SGLT2 抑制对充血性心力衰竭有益作用的新靶点机制(肾神经)
- 批准号:
10669642 - 财政年份:2021
- 资助金额:
$ 11.96万 - 项目类别:
Novel target mechanism (renal nerves) for the beneficial actions of SGLT2 inhibition in congestive heart failure
SGLT2 抑制对充血性心力衰竭有益作用的新靶点机制(肾神经)
- 批准号:
10472675 - 财政年份:2021
- 资助金额:
$ 11.96万 - 项目类别:
Novel target mechanism (renal nerves) for the beneficial actions of SGLT2 inhibition in congestive heart failure
SGLT2 抑制对充血性心力衰竭有益作用的新靶点机制(肾神经)
- 批准号:
10275320 - 财政年份:2021
- 资助金额:
$ 11.96万 - 项目类别:
I-Corps: Machine Learning based Clinical Decision Support Tool to Predict 30-day Hospital Readmissions for Congestive Heart Failure Patients
I-Corps:基于机器学习的临床决策支持工具,可预测充血性心力衰竭患者 30 天再入院情况
- 批准号:
2039546 - 财政年份:2020
- 资助金额:
$ 11.96万 - 项目类别:
Standard Grant
Development of therapeutic strategy against congestive heart failure by food ingredients.
通过食品成分开发针对充血性心力衰竭的治疗策略。
- 批准号:
20K05918 - 财政年份:2020
- 资助金额:
$ 11.96万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Stress and Congestive Heart Failure: A mechanistic clinical trial
压力和充血性心力衰竭:机械临床试验
- 批准号:
10657561 - 财政年份:2020
- 资助金额:
$ 11.96万 - 项目类别:
Stress and Congestive Heart Failure: A mechanistic clinical trial
压力和充血性心力衰竭:机械临床试验
- 批准号:
10452504 - 财政年份:2020
- 资助金额:
$ 11.96万 - 项目类别:
Stress and Congestive Heart Failure: A mechanistic clinical trial
压力和充血性心力衰竭:机械临床试验
- 批准号:
10200143 - 财政年份:2020
- 资助金额:
$ 11.96万 - 项目类别:














{{item.name}}会员




